Literature DB >> 6253048

Enzyme activities in human fetal and neoplastic tissues.

A Herzfeld, O Greengard.   

Abstract

The concentrations of ten or 12 enzymes involved in the metabolism of DNA, collagen, amino acids, or glucose have been determined in variants of human intestinal and pulmonary tissues. In comparison to nonneoplastic adult colon, normal fetal colon had elevated concentrations of thymidine kinase, peptidyl proline hydroxylase, phosphoserine phosphatase, ornithine transcarbamylase, gamma-glutamyl transpeptidase, and ornithine aminotransferase. Raised activities of the first five of these enzymes, and of hexokinase, glucose-6-phosphate dehydrogenase, and pyrroline-5-carboxylate reductase distinguishes neoplastic from nonneoplastic sections of adult colon. Study of a wide range of pulmonary specimens permitted comparisons of different types of tumors, and revealed some subtle differences between lungs of noncancer patients and nonneoplastic portions of host lungs. The concentrations of eight previously identified enzymic indicators were less in moderately or well differentiated than in poorly differentiated pulmonary adenocarcinomas. The latter differed from epidermoid carcinomas (also poorly differentiated) by containing lower concentrations of thymidine kinase (both soluble and particulate) and hexokinase.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253048     DOI: 10.1002/1097-0142(19801101)46:9<2047::aid-cncr2820460924>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Modulatory Role of Shorea robusta Bark on Glucose-metabolizing Enzymes in Diethylnitrosamine Induced Hepatocellular Carcinoma in Rats.

Authors:  A Kalaiselvan; T Anand; K Gokulakrishnan; M C Kamaraj; S Velavan
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

2.  Cytofluorometric determination of thymidine kinase activity in a mixture of normal and neoplastic cells.

Authors:  M Hengstschläger; E Wawra
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.